SANUWAVE Health, Inc Common Stock
Yahoo Finance • 13 days ago
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance
EDEN PRAIRIE, Minn., July 13, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the “Company” or “Sanuwave”) (NASDAQ: SNWV), a leading provider of FDA-cleared directed energy systems used in advanced wound care, today announced that revenu... Full story
Yahoo Finance • 17 days ago
Top Biotech Gainers: VRAX Jumps 100% After Fosun Deal, FBRX Soars On Vitiligo Data, TRAX On Watch
(RTTNews) - Today's top biotech gainers include Virax Biolabs, following its agreement with Fosun Diagnostics; Forte Biosciences, after reporting positive vitiligo data; Connect Biopharma, with a key near-term catalyst ahead; and SANUWAVE... Full story
Yahoo Finance • 2 months ago
Sanuwave (SNWV) Q4 2025 Earnings Transcript
Image source: The Motley Fool. DATE Wednesday, May 13, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Morgan Frank Chief Financial Officer — Peter Sorensen Full Conference Call Transcript Let's dig into what was a g... Full story